MedPath

Nisoldipine

Generic Name
Nisoldipine
Brand Names
Sular
Drug Type
Small Molecule
Chemical Formula
C20H24N2O6
CAS Number
63675-72-9
Unique Ingredient Identifier
4I8HAB65SZ

Overview

Nisoldipine is a 1,4-dihydropyridine calcium channel blocker. It acts primarily on vascular smooth muscle cells by stabilizing voltage-gated L-type calcium channels in their inactive conformation. By inhibiting the influx of calcium in smooth muscle cells, nisoldipine prevents calcium-dependent smooth muscle contraction and subsequent vasoconstriction. Nisoldipine may be used in alone or in combination with other agents in the management of hypertension.

Background

Nisoldipine is a 1,4-dihydropyridine calcium channel blocker. It acts primarily on vascular smooth muscle cells by stabilizing voltage-gated L-type calcium channels in their inactive conformation. By inhibiting the influx of calcium in smooth muscle cells, nisoldipine prevents calcium-dependent smooth muscle contraction and subsequent vasoconstriction. Nisoldipine may be used in alone or in combination with other agents in the management of hypertension.

Indication

For the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.

Associated Conditions

  • Hypertension

FDA Approved Products

Nisoldipine
Manufacturer:Mylan Pharmaceuticals Inc.
Route:ORAL
Strength:40 mg in 1 1
Approved: 2017/06/28
NDC:0378-2224
Nisoldipine
Manufacturer:Mylan Pharmaceuticals Inc.
Route:ORAL
Strength:30 mg in 1 1
Approved: 2017/06/28
NDC:0378-2223
Nisoldipine
Manufacturer:Mylan Pharmaceuticals Inc.
Route:ORAL
Strength:20 mg in 1 1
Approved: 2017/06/28
NDC:0378-2222
Nisoldipine
Manufacturer:Mylan Pharmaceuticals Inc.
Route:ORAL
Strength:17 mg in 1 1
Approved: 2022/09/30
NDC:0378-2097
Nisoldipine
Manufacturer:Mylan Pharmaceuticals Inc.
Route:ORAL
Strength:34 mg in 1 1
Approved: 2022/09/30
NDC:0378-2099

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath